J7515 HCPCS code: Cyclosporine, oral, 25 mg
J7515 is the HCPCS Level II code for cyclosporine, oral, 25 mg. In 2024 Medicare paid an average of $0.64 per service for J7515 across 6,857,732 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1800 per day on DME suppliers. Medicare volume fell 13% from 2022 to 2024 (7,889,433 to 6,857,732 services). In 2024, 2,912 suppliers billed Medicare for J7515 (purchases), serving 5,708 beneficiaries; California, New York, Texas accounted for 27% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2000-01-01 |
| Last action effective | 2000-01-01 |
Who bills J7515 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 2,912 |
| Referring clinicians | 4,150 |
| Medicare beneficiaries | 5,708 |
| States with claims | 51 |
| Share of services in top 3 states (California, New York, Texas) | 27% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 3,213 | 6,343 |
| 2023 | 3,164 | 6,001 |
| 2024 | 2,912 | 5,708 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7515, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 7,889,433 | 6,343 | $0.76 | $0.57 |
| 2023 | 7,330,538 | 6,001 | $0.72 | $0.54 |
| 2024 | 6,857,732 | 5,708 | $0.85 | $0.64 |
States with the most J7515 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 846,815 | $0.64 |
| New York | 497,794 | $0.64 |
| Texas | 484,733 | $0.64 |
| Ohio | 384,194 | $0.63 |
| Minnesota | 334,488 | $0.63 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1800 | CMS Policy |
| outpatient hospital claims | 90 | Clinical: Data |
What changed for J7515
- 2000-01-01: J7515 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7515?
J7515 is the HCPCS Level II code for cyclosporine, oral, 25 mg. Short descriptor: "Cyclosporine oral 25 mg".
How much does Medicare pay for J7515?
In 2024, the average Medicare payment was $0.64 per service (average allowed $0.85).
Does Medicare cover J7515?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J7515 can be billed per day?
1800 on DME suppliers; 90 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7515
- Watch J7515 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7515
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.